SERUM INSTITUTE OF INDIA SII
COVID-19 Vaccine: Serum Institute of India Restarts Manufacturing Covishield Vaccines, CEO Adar Poonawalla Confirms ‘6–7 Million Doses’ To Be Available in 90 Days
Pune Scam: Posing As Adar Poonawalla, Scammers Dupe ‘Serum Institute of India’ of Over Rs 1 Crore, 7 Arrested; Main Accused Absconding
Adar Poonawalla To Get Y Category Security; MHA Issues Order To Provide Security to CEO of SII, The Covishield Vaccine Producer
India’s COVID-19 Vaccine Drive in Pics and Videos: Sudarsan Pattnaik’s Sand Art and Congratulatory Posts on Twitter Evoke Hope for Better Days
COVID-19 Vaccine Update: Serum Institute of India Gets DCGI Permission To Manufacture Its Coronavirus Vaccine ‘Covishield’
Oxford COVID-19 Vaccine: SII Responds To Chennai Man's Rs 5 Crore Compensation Notice, Says No Relation Of Medical Condition With Vaccine Trial
Oxford Vaccine: SII Responds to Chennai Man's Rs 5 Crore Compensation Notice, Says No Relation of His Medical Condition With COVID-19 Vaccine Trial
Covishield Vaccine: Emergency Use Authorisation Request in Two Weeks, Govt Likely to Buy 300-400 Million Doses by July, Says Adar Poonawalla
Oxford COVID-19 Vaccine ‘70% Effective’, Serum Institute Chief Adar Poonawalla Says India Could Give Nod By Year-End
Google Trends